Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

This is a collection of current resources related to Nirsevimab.

161170 of over 100 results

Applied Filters:

Early Experiences With Nirsevimab: Perspectives From Newborn Hospitalists
2024 · Yale School of Medicine, · Stanford University, · Seattle Children's Hospital, · The University of Chicago Medicine, · Nationwide Children's Hospital, · Yale University
This article discusses the implementation of newly developed nirsevimab into clinical practice. Approved in July 2023, it is costly and has supply issues. Hospitals struggle …
Exploring Parental Perspectives: Maternal RSV Vaccination Versus Infant RSV Monoclonal Antibody
2024 · Children's Health Ireland, · University College Dublin
This article looks at the comparison between two new ways to protect babies from respiratory syncytial virus (RSV): a maternal vaccine and an infant monoclonal …
Impact of Universal Immunization Program With Monoclonal Antibody Nirsevimab on Reducing the Burden of Serious Bronchiolitis That Need Pediatric Intensive Care
2024 · Hospital Sant Joan de Déu Barcelona, · University of Barcelona
This study in Catalonia, Spain analyzed the effects of immunizing children with nirsevimab on bronchiolitis cases in pediatric intensive care units (PICU). The research compared …
High Uptake of Respiratory Syncitial Virus Prevention for Neonates in a Military Treatment Facility
2024 · Brooke Army Medical Center
This article discusses a study on the use of nirsevimab for infants and an RSV vaccine for pregnant women at a military hospital. It found …
Monoclonal Antibody Therapies in Respiratory Syncytial Virus Prophylaxis-An Umbrella Review
2024 · University of Eastern Finland, · Kuopio University Hospital
This article reviews the use of monoclonal antibodies to prevent respiratory syncytial virus (RSV) in infants. It describes how RSV causes many hospitalizations and deaths …
Real-World Effectiveness of Nirsevimab Against Respiratory Syncytial Virus: A Test-Negative Case-Control Study
2024 · Yale School of Medicine, · Yale University
This article describes a study that evaluated the effectiveness of nirsevimab in preventing RSV infections in infants. It included 3,090 infants and found that nirsevimab …
Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date
2024 · University of the Witwatersrand
This article discusses recent research around respiratory syncytial virus (RSV), which is a common cause of lower respiratory tract infection in children, leading to long-term …
Nirsevimab Administration During the Birth Hospitalization
2024 · Albert Einstein College of Medicine, · Children's Hospital at Montefiore
This brief report describes a study focused on the birth hospital nirsevimab administration rate and compared it to the hepatitis B vaccine rate in the …
Factors Associated With Nirsevimab Uptake in Healthy Newborns
2024 · Yale School of Medicine, · Yale University
This research brief discusses a study that looks at factors affecting the use of nirsevimab, a new antibody for RSV, in newborns. It explains how …
Nirsevimab Effectiveness Against Severe RSV Infection in the Primary Care Setting
2024 · Fisabio-Public Health, · Instituto de Salud Carlos III, · University of Valencia
This study in Spain evaluated nirsevimab's efficacy in preventing respiratory syncytial virus (RSV) infections in infants under ten months. The immunization campaign targeted all infants …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie
161170 of over 100 results